Louisiana Cannabis Policy: New Penalties Near Educational Institutions
Louisiana lawmakers are advancing a bill that could significantly alter the state’s cannabis legal framework, introducing stricter penalties for cannabis use near educational institutions. House Bill 568 (HB 568), sponsored by Representative Gabe Firment (R), proposes jail sentences and fines for individuals found smoking, vaping, or otherwise using controlled dangerous substances within 2,000 feet of any school property, including college campuses. This development represents a notable shift in Louisiana cannabis policy, drawing scrutiny from industry observers and reform advocates.
Legislative Details of HB 568
The legislation, which passed the House of Representatives with a 59-34 vote, now proceeds to the Senate for further consideration. As reported by Marijuana Moment, HB 568 specifically targets individuals who violate drug laws “while smoking, vaping, or otherwise abusing such controlled dangerous substance while on any property used for school purposes by any school, within two thousand feet of any such property, or while on a school bus.” The proposed penalties include incarceration for up to one year and a fine of up to US$1,000. This broad application of the law, encompassing areas extending over a third of a mile from school properties, has raised concerns about its potential impact on urban and suburban populations.
Industry Reaction and Policy Context
The Marijuana Policy Project (MPP), a pro-legalization advocacy group, has characterised the proposed penalties as “incredibly draconian,” suggesting they could reverse recent progress in cannabis reform within the state. Kevin Caldwell, MPP’s Southeast legislative manager, highlighted that the bill “would make cannabis use a felony in huge swaths of urban and suburban areas,” potentially leading to a student being incarcerated for a year for consuming in a college dorm room. This contrasts with legislative actions taken in 2021, when then-Governor John Bel Edwards (D) signed a bill that decriminalised the possession of up to 14 grams of marijuana, removing the threat of jail time for such offenses. The current bill’s provisions, therefore, are viewed by some as an attempt to reintroduce severe penalties for minor cannabis-related infractions.
Broader Louisiana Legislative Landscape
Despite the advancement of HB 568, other legislative efforts in Louisiana indicate a more varied approach to cannabis and related substances. The Louisiana Senate recently passed a separate bill to permit patients with terminal and irreversible conditions to use medical marijuana in hospitals. Furthermore, the Senate also approved legislation aimed at establishing a psychedelic-assisted therapy pilot program. This program intends to utilise opioid settlement funds to finance clinical trials for alternative treatments, including psilocybin and ibogaine. Concurrently, Representative Candace Newell (D) introduced the “Adult-Use Cannabis Pilot Program Regulation and Enforcement Act,” seeking to evaluate the feasibility of expanding and codifying adult-use cannabis reform in the state. However, previous attempts by Representative Newell to advance similar pilot programs and tax systems for adult-use cannabis have not succeeded in the conservative legislature, underscoring the complex and often contradictory nature of Louisiana cannabis policy discussions.
The progression of HB 568 through the Louisiana House signals a potential tightening of cannabis enforcement, particularly in areas surrounding educational institutions. For businesses and individuals operating within the state’s medical cannabis framework, understanding these evolving legal parameters is crucial. The bill’s journey to the Senate will be closely monitored by stakeholders interested in the future direction of cannabis regulation and its broader implications for public policy and access in Louisiana.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
